Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Annandale, New Jersey 08801


Purpose:

Examine the ability of thymopentin (Timunox) to: Reduce the amount and/or frequency of virus isolation. Stimulate the immune system and alter the clinical findings in patients infected with HIV who do not yet have AIDS.


Criteria:

Inclusion Criteria Concurrent Treatment: Allowed: - Aerosolized pentamidine. Prior Medication: Allowed: - Aerosolized pentamidine. Exclusion Criteria Co-existing Condition: Patients with the following are excluded: - AIDS as defined by the CDC (except for those with HIV "wasting syndrome"). - Significant hepatic disease. - Thrombocytopenia (< 75000 platelets/mm3). - Abnormal chest x-ray (indicative of active disease (opportunistic infection)) within 30 days prior to entry. - Hemophilia A or B or other hematologic disorders requiring current or previous administration of blood products. - Known hypersensitivity to thymopentin. Prior Medication: Excluded within 30 days of study entry: - Immunomodulatory or experimental therapy. - Excluded within 90 days of study entry: - Zidovudine (AZT). Patients must not have: - AIDS as defined by the CDC (except for those with HIV "wasting syndrome"). - Significant hepatic disease. - Thrombocytopenia (< 75000 platelets/mm3). Patients with the following conditions are included: - Seropositive for HIV-1 (ELISA assay) confirmed by Western blot. - HIV-1 p24 antigen must be detected in supernatant fluids from co-cultures of patient's peripheral blood monocytes (PBMC) on two separate occasions. - HIV "wasting syndrome". - Must voluntarily sign consent. History of intravenous drug abuse.


NCT ID:

NCT00002051


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Annandale, New Jersey 08801
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.